Cannabis Investing Relevium Executes LOI to Acquire Montreal Biopharma Contract Manufacturing Company
Cannabis Investing Relevium’s Subsidiary BGX E-Health Secures One Million Dollar Export Contract for the Middle East
Cannabis Investing Relevium Enters Into LOI to Unlock Value of Wholly Owned Subsidiary BGX E-Health LLC and Announces Conference Call With CEO
Cannabis Investing Relevium Acquires 100 Percent of Late Stage Processing and Medical Sales Applicant Weedsense
Cannabis Investing Relevium Enters Into Manufacturing Agreement With Bio V Pharma and Registers 400 NPN Numbers With Health Canada
Accent Trial Data Demonstrates that Narmafotinib + Chemotherapy Combination Superior to Chemotherapy Alone
High Grade surface silver results up to 920g/t Ag recorded ~300m to the north and ~150m to the south of Elizabeth Hill mineralisation
